galgo12

Dr. Niha Sultana

Assistant Professor

Research Interests

  • Design and optimization of nanotechnology-based drug delivery systems, including microneedle-mediated and transdermal formulations. 
  • Formulation development and characterization of polymer-based biomaterials for enhanced therapeutic efficacy. 
  • In vivo pharmacokinetic and pharmacodynamic evaluations for assessing drug safety and performance. 
  • Toxicological and biocompatibility studies aligned with regulatory and ISO 10993 standards. • Application of Quality by Design (QbD) and analytical techniques to ensure product quality, reproducibility, and regulatory compliance.

Total experience

  • Industry

    9 months in Regulatory affairs

  • Research Experience

    5 Years

Publications & Patents

Publications: ~15 Journal Articles, 1 Granted Patent 

Citations: ~ 179 (8 h‑index) 

List of Journal Articles/Books/Book chapter/Patents (Only titles) 

Patent 

Microneedle-Based Transdermal Patch Formulation of Raloxifene and Cholecalciferol for the Management of Osteoporosis.

Articles 

  1. Dissolving microneedle transdermal patch loaded with Risedronate sodium and Ursolic acid bipartite nanotransfersomes to combat osteoporosis: Optimization, characterization, in vitro and ex vivo assessment.
  2. Exploring new frontiers in drug delivery with minimally invasive microneedles: fabrication techniques, biomedical applications, and regulatory aspects.
  3. Development and validation of UV- spectroscopy based stability indicating method for simultaneous estimation of risedronate sodium and Ursolic acid.
  4. 3D Printing in pharmaceutical manufacturing: Current status and future prospects. 5. Development and validation of UV- spectroscopy based stability indicating method for simultaneous determination of fluoxetine hydrochloride and embelin.
  5. Engineering of QbD driven and ultrasonically shaped lyotropic liquid crystalline nanoparticles for Apigenin in the management of skin cancer.
  6. Insights into Pharmacological Potential of Apigenin through various Pathways on a Nanoplatform in Multitude of Diseases.
  7. Quality by Design-Optimized Glycerosome-Enabled Nano sunscreen Gel of Rutin Hydrate. 9. Medicinal potential of embelin and its nano formulations: An update on the molecular mechanism and various applications.
  8. BBD assisted in-situ nanoliposomes of esculin hydrate via intranasal delivery for the amelioration of Parkinson's disease.
  9. Tailoring and Evaluation of Berberine Loaded Transethosomal Gel for Effective Transdermal Delivery: Optimization, Characterization, and in vitro Evaluation.
  10. Nanoliposomal in situ gel of fluoxetine and embelin as a potent intervention for depression via the intranasal route in CUMS animal model.
  11. Navigating into the Paradigm of Nose-to-brain Delivery of Nanotherapeutics and their Repurposing as Nanotheranostics for Neurodegenerative Diseases.
  12. An overview of phospholipid enriched-edge activator-based vesicle nanocarriers: new paradigms to treat skin cancer.
  13. 5-Fluorouracil-and Sesamol-Loaded Transliposomal Gel for Skin Cancer: In Vitro, Ex Vivo, and Dermatokinetic Evaluation. 

Expertise

I am a passionate and research-driven scientist with a PhD in Pharmaceutics, specializing in nanotechnology-based drug delivery systems and biomaterials. My work focuses on developing and optimizing innovative formulations such as microneedle-mediated transdermal patches and targeted nanoparticles for enhanced therapeutic outcomes. I have hands-on experience in formulation design, analytical characterization, and in vivo preclinical studies. I have experience in regulatory affairs where I have learnt about the regulatory compliance of pharmaceutical products to ensure their safety and efficacy. I have one patent and several peer-reviewed articles 

in reputed journals. My work in recognized internationally and honored with best poster award in an international conference in UK.

Educational Qualifications

  • Ph.D in Pharmaceutics